The aim of this study was to investigate the phytochemical profile of the methanol extract of the aerial parts of Sedum sediforme and to identify its secondary metabolites. By means of chromatographic separation and enrichment of compounds, HPLC-ESI-MS, HRMS, 1D-, 2D-NMR and/or comparison with reference compounds, three triterpenes, two sterols, ten flavonoids and twelve phenolic compounds were identified, together with two new compounds, i.e. (2R * , 3R * )-5,7-dihydroxy-2,3-dimethyl-4-chromanone-7-O-ß-D-glucoside (27) and butan-2-O-rutinoside (28). Out of the 29 identified secondary metabolites, 18 are described as ingredients of S. sediforme herein for the first time. Furthermore, myricitrin, one of the major constituents, was tested for its ability to inhibit different enzymes within the arachidonic acid cascade in order to determine its anti-inflammatory properties. Whereas there was only either weak or no inhibition of the microsomal prostaglandin E 2 synthase-1 (mPGES-1) and the soluble epoxide hydrolase (sEH), myricitrin showed strong inhibition of 5-lipoxygenase (5-LO), with an IC 50 of 7.8 ± 0.2 µM.
Sedum sediforme (Jacq.) Pau, family Crassulaceae, is generally known as pale stonecrop. It is a widespread plant in the Mediterranean climatic zone where it is used as an ingredient of the Mediterranean diet [1] . Some Sedum species are used in Greek folk medicine to treat various diseases such as scurvy, epilepsy, bladder disease and constipation. Furthermore, S. acre is used in China to cure burns, and the roots of S. roseum for the treatment of headache [2] .
Romojaro et al. reported a high total phenolic content in S. sediforme [1] . These results are in agreement with a recent study by Ertas et al. in which a methanol extract of S. sediforme was analyzed by an UHPLC-ESI-MS/MS method for phenolic compounds and flavonoids. This study showed that quercetin, rutin, naringenin, protocatechuic acid, p-coumaric acid, caffeic acid, and chlorogenic acid are present in the methanol extract. However, the quantified amount of the identified compounds was lower than the observed total phenolic content suggesting the presence of additional phenolic constituents in the methanol extract [3] . In a previous phytochemical study by Sakar et al. some additional phenolic components are described as ingredients of the flowers of S. sediforme, i.e. free gallic acid, phlorin, picraquassioside D, 5,3',5'-trimethoxy-epigallocatechin-3-O-gallate, epigallocatechin-3gallate, epicatechin-3-gallate, limocitrin-3-O-glucoside, kaempferol-3-O-rhamnoside, quercitrin, and myricitrin [4] .
All in all, the phytochemical profile of S. sediforme has not been completely investigated. Therefore, the aim of our study was to explore the phytochemical profile of the methanol extract of the aerial parts in detail by means of a combination of techniques, i.e. chromatographic separation and enrichment of compounds, HPLC-ESI-MS, HRMS, 1D-and 2D-NMR, and/or comparison with reference compounds. Recent studies showed that extracts of some Sedum species exhibit anti-inflammatory effects e.g. in the croton oil-induced mouse ear edema and rat paw edema assays [5] [6] [7] [8] . Flavonoids are considered to be responsible for these effects, but the molecular mode of action is only partially understood. To the best of our knowledge, the antiinflammatory effects of S. sediforme have never been investigated. In order to obtain an insight into the anti-inflammatory potential of S. sediforme, we evaluated the anti-inflammatory activity of myricitrin, a flavonol glycoside which is one of the main components of the methanol extract of this species.
The dried and ground aerial parts of S. sediforme were extracted with methanol using accelerated solvent extraction (ASE). Separation and enrichment of compounds was achieved using different chromatographic techniques, i.e. gradient fast centrifugal partition chromatography (FCPC) ® , silica gel and Sephadex ® column chromatography (CC), as well as preparative thin layer chromatography. Twenty-six compounds were identified as phlorin (1) [9] , picraquassioside D (2) [4] , protocatechuic acid (3) [10] , phloroglucin-1-O-(6''-galloyl-glucoside) (4) [11] , gallincin (5) [12] , aesculetin (6) [13] , caffeic acid (7) [10] , piceol (8) [14] , syringic acid (9) [15] , eriodictyol-4',7-O-diglucoside (10) [16] , apocynin (11) [17] , eriodictyol-4'-O-glucoside (12) [18] , myricitrin (13) [19] , eriodictyol (14) [13] , quercitrin (15) [20] , myricetin-3-O-(2''galloylrhamnoside) (16) [21] , myricetin-3-O-(3''-galloyl-rhamnoside) (17) [21] , naringenin (18) [22] , (2R * , 3R * )-5,7-dihydroxy-2,3-dimethyl-4-chromanone (19) [23] , quercetin (20) [24] , luteolin (21) [24] , taraxeryl acetate (22) [25] , lupeol (23) [26] , germanicyl formate (24) [27] , ß-sitosterol (25) [10] , and ß-sitosterol-3-O-glucoside (26) Compound 27 was identified as the 7-O-ß-D-glucoside of (2R * , 3R * )-5,7-dihydroxy-2,3-dimethyl-4-chromanone, an aglycone which was previously described by Mutanyatta-Comar et al. [23] . The 1 H NMR spectrum showed two doublets at δ H 1.19 (3H, J = 7.0 Hz) and δ H 1.48 (3H, J = 6.3 Hz) representing two methyl groups bonded to the sp 3 hybrid carbons C-2 and C-3, respectively. The proton signals of C-2 and C-3 resonated at δ H 4.21 (1H, dq, J = 11.2 / 6.2 Hz) and δ H 2.62 (1H, dq, J = 11.2 / 6.9 Hz), respectively. The meta coupled aromatic proton signals at δ H 6.14 (1H, d, J = 2.2 Hz) and δ H 6.16 (1H, d, J = 2.2 Hz) could be allocated to C-8 and C-6, respectively. The position of the glucose moiety was established by the HMBC spectrum which showed long range coupling between the anomeric proton (δ H 4.96, 1H, d, J = 7.3 Hz) and C-7 (δ C 167.3) of the chromanone aglycone. All 1 H and 13 C NMR signal assignments were confirmed by COSY, HSQC, and HMBC data and are in good agreement with those reported by Mutanyatta-Comar et al. [23] , indicating also the relative 2R * , 3R * configuration of the molecule. The high resolution mass spectrum showed a pseudomolecular ion peak [M -H + HCO 2 H]at m/z 415.1246, which is in accordance with the suggested elemental composition of C 18 H 23 O 11 . The absolute configuration of the glucose moiety was determined by hydrolysis and L-cysteine methyl ester derivatization experiments in comparison with D-glucose as reference compound. The derivatized hydrolysis products of 27, the derivatized Dglucose and a mixture (1:1) thereof were analyzed by HPLC-ESI-MS. The accordance of the retention times (Rt) of the reaction products of the reference sugar (Rt = 4.8 min / 5.9 min) with those of the derivatized hydrolysis products of compound 27 (Rt = 4.8 min / 5.9 min) indicated the D configuration of the glucose moiety of 27.
Also the structure of the new alkyl glycoside 28 was elucidated by means of 1D-and 2D-NMR spectroscopy. The 1 H NMR spectrum displayed one triplet at δ H 0.95 (3H, J = 7.5 Hz) and one doublet at δ H 1.26 (3H, J = 6.3 Hz), which were assigned to two methyl groups. One methine proton signal at δ H 3.71 (1H, dd, J = 12.3 / 6.2 Hz) and two methylene proton signals at δ H 1.48 (1H, m) and δ H 1.62 (1H, m) indicated the presence of a butan-2-oxy group [29] . The sugar moiety could be identified as rutinose, which was shown by two anomeric proton signals at δ [31] might provide an indication of its absolute configuration. Since it displays a negative optical rotation, it is likely that compound 28 bears the 2-butanol moiety with an R configuration in position 2. However, further experiments are needed to verify this hypothesis.
An HPLC-ESI-MS method was developed and optimized to analyze the methanol extract of S. sediforme. In total, 23 constituents could be identified (Figure 2 ) using chromatographic and mass spectromic features and by comparison with the reference compounds. The triterpenes (22, 23, and 24) and sterols (25 and 26) could not be assigned, because ionization of these components was not sufficient.
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Additionally, HPLC-ESI-MS analysis led to the identification of one further compound, i.e. gallic acid (29) . The identity of this secondary metabolite was confirmed by comparison with a reference compound. A HRMS method was used to verify the identity of all compounds. Data obtained from the HPLC-ESI-MS and the HRMS analysis, e.g. HPLC Rt, HRMS suggested elemental composition, HRMS (m/z), calculated (m/z), and ± ∆ (ppm) are summarized in Table 1 .
Furthermore, myricitrin (13), one of the major components of the extract, was tested for its inhibitory activity against different enzymes within the arachidonic acid cascade to determine its antiinflammatory properties in more detail. Although there is either only weak or no inhibition of the microsomal prostaglandin E 2 synthase-1 (mPGES-1) and the soluble epoxide hydrolase (sEH), 13 exhibied a strong inhibition of 5-lipoxygenase (5-LO) with an IC 50 of 7.8 ± 0.2 µM (Figure 3 ).
An intensive literature search revealed that the identified compounds 5, 6, 7, 20, and 21 are also reported to inhibit 5-LO in a low micromolar range with IC 50 values of 8.40 [32] , 6.60 [33] , 3.47 [34] , 3.29 [35] , and 2.25 µM [35] , respectively. Our findings, together with published literature data, suggest that S. sediforme bears anti-inflammatory potential. The inhibition of 5-LO and the well-described anti-oxidant activity [3] might both contribute to the overall bioactivity. An anti-inflammatory effect would support the suggestion to use S. sediforme as an ingredient of functional food due to its well-known anti-oxidant properties [1, 3] . However, further studies need to be performed to confirm this.
In comparison with previous phytochemical studies [3, 4] of S. sediforme, 18 additional secondary metabolites, including two new natural products, were identified within this work. Moreover, the developed HPLC-ESI-MS method is a valuable tool that can be applied also for profiling of other extracts or organs of S. sediforme or even other Sedum species.
Experimental
General experimental procedure: The extraction of the plant material was accomplished with an ASE300 apparatus from Dionex. FCPC ® was performed on a Kromaton instrument equipped with a 1000 mL rotor and fractions were collected with a BüchiB-684 fraction collector. CC was carried out with Sephadex ® LH-20 and silica gel. Preparative thin layer chromatography (TLC) was carried out on precoated silica gel 60 F 254nm glass plates from Merck (20 × 20 cm 
Extraction and chromatographic separation:
The dried and ground aerial parts of S. sediforme (60 g) were extracted with methanol using ASE. The extract yield amounted to 7.72 g. The crude methanol extract (5 g) was subjected to a gradient FCPC ® separation using biphasic systems of n-hexane: EtOAc: BuOH: EtOH: 10% acetic acid (10:5:0:5:10, 5:10:0:5:10, 1:14:0:5:10, 1:12:2:5:10, and 1:9:5:5:10). The lower phase of the first solvent system (aqueous phase) was used as stationary phase. The upper phase of each solvent system (organic phase) was used as mobile phase. A volume of 500 mL was used of every organic phase, successively. The analysis was conducted in ascending mode with a flow rate of 15 mL/min. This procedure yielded 32 fractions (a1 -a32), which were combined on the basis of qualitative TLC evaluation (elution, CH 2 Cl 2 : MeOH 9:1, v/v; vanillin/sulfuric acid detection). Fraction a11 contained mainly naringenin (18) and fraction a21 largely myricitrin (13) . Fraction a2 was subjected to gradient silica gel CC (7.5 × 280 mm) using mixtures of cyclohexane and CH 2 Cl 2 , as well as CH 2 Cl 2 and MeOH. The polarity was successively increased to give 28 sub-fractions (a2b1 -a2b28). Sub-fraction a2b6 contained germanicyl formate (24), a2b7 taraxeryl acetate (22) , a2b14 lupeol (23), and a2b16 ß-sitosterol (25) . Fraction a6 was separated by preparative TLC (CH 2 Cl 2 : MeOH 94:6, v/v) to obtain (2R * , 3R * )-5,7-dihydroxy-2,3-dimethyl-4-chromanone (19) and ß-sitosterol-3-O-glucoside (26) . Fraction a13 was applied to CC (Sephadex ® LH-20, 10 × 244 mm) eluted with EtOAc: MeOH in a 1:1 (v/v) ratio. Three flavonoids could be identified as eriodictyol (14) , luteolin (21) , and quercetin (20) , as well as two acetophenones piceol (8) and apocynin (11) . Fraction a17 was separated by preparative TLC (CH 2 Cl 2 : MeOH 9:1, v/v) to obtain syringic acid (9) , aesculetin (6), gallincin (5), caffeic acid (7), and protocatechuic acid (3). Fractions a20, a23, and a26 were subjected to CC (Sephadex ® LH-20, 10 × 233 mm, 10 × 285 mm, and 15 × 230 mm, respectively) eluted with MeOH, respectively. (2R * , 3R * )-5,7-Dihydroxy-2,3-dimethyl-4-chromanone-7-O-ß-Dglucoside (27, 5.19 mg, purity 75% determined by 1 H NMR), eriodictyol-4'-O-glucoside (12), quercitrin (15), myricetin-3-O-(2''galloyl-rhamnoside) (16) , and myricetin-3-O-(3''-galloylrhamnoside) (17) resulted from the fractions of a20. Picraquassioside D (2) and phloroglucin-1-O-(6''-galloyl-glucoside) (4) were obtained by fractionation of a23. Butan-2-O-rutinoside (28, 1.26 mg, purity 95% determined by 1 H NMR), phlorin (1), and eriodictyol-4',7-O-di-glucoside (10) could be identified from the fractions of a26. The purity of these compounds varied between 70% and 95%. Some of the compounds were analyzed even as mixtures. Structure elucidation was performed by means of NMR spectroscopy and based on high resolution mass spectra.
HPLC-ESI-MS analysis:
The analysis of the methanol extract of S. sediforme was carried out on an Agilent 1100 HPLC system connected to a Bruker-Daltonics Esquire 3000 plus ion trap. Electrospray ionization (ESI) was used alternately in positive and negative mode. The extract was separated with a HyperClone 5 µ ODS (C18) 120 Å column (150 × 4.60 mm, 5 µm) from Phenomenex. Elution was achieved with a binary solvent system consisting of solvent A (water with 0.9% formic acid and 0.1% acetic acid, v/v) and solvent B (methanol) at a temperature of 40°C. The gradient was as follows: 0 -35 min, 10 -52% B; 35 -50 min, 52 -98% B; 50 -60 min, 98% B. After each analysis the column was re-equilibrated with the initial conditions for 10 min. The flow rate was 1.0 mL/min. Injected were 10 µL of a 1 mg/mL solution in methanol (injected amount of the extract: 10 µg).
UHPLC-HRMS analysis:
The high resolution mass spectrometry was performed on a Thermo Scientific UHPLC-LTQ-Orbitrap system equipped with an ESI interface, operating in negative mode. A Supelco Ascentis ® Express C18 column (100 × 2.1 mm, 2.7 μm, Thermo Scientific) was utilized. The following gradient solvent system was used for elution: 95% of solvent A (water with 0.1% formic acid, v/v) and 5% of solvent B (methanol) for 2 min, adjusting linearly to 10% B at 4.5 min, then 25% B at 25 min, and 95% B at 28 min. The last solvent composition (95% B) was maintained for 30 min, followed by a return to the initial conditions in 1.5 min and a re-equilibration step of 1.5 min prior to the next run. The flow rate was set to 0.4 mL/min. Injected were 10 µL of a 100 µg/mL solution (injected amount of the sample: 1 µg).
Acid hydrolysis and L-cysteine methyl ester derivatization experiments:
The sample (0.1 mg) was hydrolyzed in 1 mL 2 M trifluoroacetic acid at 100°C for 2 h. The trifluoroacetic acid was evaporated and the hydrolysis products were dissolved in 1 mL water (HPLC grade), which was subsequently evaporated. This washing procedure was repeated twice. After further addition of 1 mL water, the aglycon was extracted with ethyl acetate (3 × 1 mL). The water was removed and the sample dried under vacuum in a desiccator. The D or L configuration of the monosaccharides was determined as follows: The dried hydrolyzed sugar mixture was dissolved in pyridine (300 µL) and L-cysteine methyl ester (0.15 mg) was added. The mixture was stirred at 60°C for 1 h. The analysis of the mixture was performed using HPLC-ESI-MS (Agilent 1100 connected to a Bruker-Daltonics Esquire 3000 plus ion trap). The sample was separated with an Atlantis ® HILIC Silica 3 µm (4.6 × 150 mm) column from Waters at a temperature of 25°C and a binary solvent system consisting of solvent A (MeCN: H 
5-Lipoxygenase assay:
E.coli BL21 was transformed with pT3-5LO plasmid, recombinant 5-LO protein was expressed at 37°C, and 5-LO was purified as described [36] . Purified 5-LO (0.5 µg) was diluted with PBS/EDTA, 1 mM ATP was added, and pre-incubated with the test compounds (e.g. myricitrin (13) at 0.1, 1, 10, and 100 µM). After 5 -10 min at 4°C, samples were pre-warmed for 30 sec at 37°C, and 2 mM CaCl 2 plus 20 µM AA were added to start 5-LO product formation. The reaction was stopped after 10 min at 37°C by addition of 1 mL ice-cold methanol and the formed metabolites (all-trans isomers of LTB 4 and 5-H(P)ETE) were analyzed by RP-HPLC as described [36] . All compounds were analyzed in 3 independent experiments, and data are given as means ± S.E.M..
